The Effect of Clonidine in Glycemia During Coronary Artery Bypass Graft With Cardiopulmonary By-pass

NCT01619436 ↗

Phase 4 Completed 46 enrolled Federal University of Juiz de Fora

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is the randomized blind research of the assessment of the different levels of glycemia during Coronary Artery Bypass Graft (CABG) with cardiopulmonary by-pass (CPB) between clonidine and placebo. As clonidine decrease the inflammatory response during cardiac surgery, the investigators would like to know if the glycemia levels in clondine group will be lower than placebo group.

Timeline

Start: 2011-01
Primary completion: 2012-01
Completion: 2012-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Clonidine	Other / unclassified	2 mg/kg	Intravenous

Indications

No indication recorded.